Target intelligence / Profile preview

MT-ND2 pseudogene 8 (MTND2P8)

Target
MTND2P8
Molecular classification
Pseudogene, Other
01

Overview

MT-ND2 pseudogene 8 (MTND2P8) is classified as a pseudogene of the mitochondrial gene MT-ND2 in Homo sapiens[2][4]. Pseudogenes typically arise from duplication or retrotransposition events and do not produce functional proteins. There is no evidence that MTND2P8 encodes any protein, nor is it directly involved in mitochondrial function, disease, or targeted by therapeutic agents. While differential expression of certain mtDNA pseudogenes has been observed in disease contexts (such as Alzheimer's disease), including other MT-ND2 pseudogene variants, these associations are not specific to MTND2P8 and are not clearly causal or mechanistically compelling[5]. MTND2P8 is not a receptor, enzyme, or transporter, and should not be considered a drug target. The functional MT-ND2 gene encodes a core subunit of mitochondrial NADH:ubiquinone oxidoreductase (complex I), which is essential for cellular respiration, but MTND2P8 does not share these properties[1][3][4]. Summary of Findings: - MTND2P8 is a pseudogene and is not a functional molecule for therapeutic targeting. - No established aliases other than full descriptive name and abbreviation. - No molecular family associations beyond "pseudogene". - No role in biological function or as a drug target. - No links to drug mechanisms, biomarkers, or safety challenges. - There may be some research interest in differential pseudogene expression in brains of Alzheimer's patients, but the literature does not support MTND2P8 as a causal or actionable target for disease intervention[5].

Other names
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2 pseudogene 8

Beyond the preview

Go deeper on MT-ND2 pseudogene 8 (MTND2P8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MT-ND2 pseudogene 8 (MTND2P8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call